Sun Pharma arm settles case with Biofrontera, to get $22.5 mn

Sun Pharmaceutical Industries on Tuesday said its arm DUSA Pharmaceuticals Inc has reached settlement with Biofrontera to resolve a litigation over misappropriation of trade secrets and unfair......

Sun eyes US skincare market

Sun Pharma, the largest Indian pharma company by value, is set to strengthen its presence in the US skincare market. Last week, Sun’s Israeli subsidiary, Taro Pharma, received the US Food and......

Looking for more acquisition: Sun Pharma

A day after it announced the $230 million deal to buy a US-based company, Sun Pharmaceutical Industries on Friday said it is looking forward to larger acquisitions as a part of its expansion......

Sun Pharma to acquire US-based DUSA for $230 million

Sun Pharmaceutical Industries on Thursday said it has inked a pact to acquire US-based DUSA Pharmaceuticals for around $230 million (around Rs 1,250 crore).Sun Pharma and DUSA Pharmaceuticals have......